| Company | Share, % |
|---|---|
 KemPharm, Inc.
|
13.24 |
| Biomea Fusion, Inc. | 7.57 |
| Pyxis Oncology, Inc. | 6.56 |
 Pliant Therapeutics, Inc.
|
5.95 |
| Vor Biopharma Inc. | 4.67 |
| Exscientia Holdings Limited | 4.47 |
 BELLUS Health Inc.
|
3.81 |
| Acumen Pharmaceuticals, Inc. | 3.15 |
 BridgeBio Pharma, Inc.
|
2.98 |
 Solid Biosciences Inc.
|
2.46 |
| Mineralys Therapeutics, Inc. | 2.33 |
| PepGen Inc. | 2.05 |
 Aldeyra Therapeutics, Inc.
|
1.92 |
 Atossa Therapeutics, Inc.
|
1.77 |
 CytomX Therapeutics, Inc.
|
1.62 |
 Cardiff Oncology, Inc.
|
1.62 |
 SQZ Biotechnologies Company
|
1.46 |
| Viracta Therapeutics, Inc. | 1.43 |
 Shattuck Labs, Inc.
|
1.39 |
| Absci Corporation | 1.05 |
| Cyteir Therapeutics, Inc. | 0.88 |
| Direct Digital Holdings, Inc. | 0.81 |
 Aemetis, Inc.
|
0.73 |
 Lineage Cell Therapeutics, Inc.
|
0.65 |
 Applied Molecular Transport Inc.
|
0.53 |
| Bausch + Lomb Corporation | 0.29 |
